Arenas APD-791 has been found to be well tolerated in a Phase Ib trial for Arterial Thrombosis. The drug dose-dependently inhibited of serotonin-mediated amplification of platelet aggregation
Filed under: Uncategorized | Tagged: 5-HT2A, 5HT2A, agonist, Arena, Inverse, phase I, Phase Ib | Leave a Comment »
